🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Month 2 and I have lost NOTHING - normal?? — looking for input Page 2

Month 2 and I have lost NOTHING - normal?? — looking for input

roxy_nash Wed, Feb 7, 2024 at 7:52 PM 37 replies 2,431 viewsPage 2 of 8
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Feb 8, 2024 at 7:39 PM#6
PurityPaulOR said:
Steady state is the thing most people miss.

I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.

46 16Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 43 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Feb 9, 2024 at 5:07 AM#7

Adding the numbers, since they settle part of this. Worth knowing that the injection site changes very little. Abdomen, thigh and upper arm are bioequivalent for semaglutide, so a site change is not a plausible explanation for a bad week.

Happy to go further on any of that.

Last edited: Feb 9, 2024 at 6:07 AM
45 15MikeFit_NJ, InsuranceTom, WendyG_ATL and 42 others
Reply Quote Save Share Report
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Feb 9, 2024 at 2:35 PM#8
TrialTracker_MD said:
I will push back on the "any working dose is fine" framing.

Adding the part of the answer the thread has not reached. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

44 14tommy_boulder, hyun_seoul, jim_asheville and 41 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
MariaRD
Member
823
4,567
Jun 2024
New Mexico
Feb 10, 2024 at 12:03 AM#9

A narrower follow-up, since the general answer is now clear:

What would you measure differently if you were starting again?

43 13rick_sfbay, maria_elpaso, anders_CPH and 40 others
Reply Quote Save Share Report
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Feb 11, 2024 at 9:33 PM#10

Closing the loop on my own question.

Update since I posted: I held at 1.7mg for a further twelve weeks and lost another 4kg slowly, which settles it for me. I was escalating because the number was available, not because I had stopped responding.

Last edited: Feb 12, 2024 at 3:33 AM
43 16kim_atl_prep, sarah_TO, wendy_avl and 40 others
Reply Quote Save Share Report

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register